发明名称 |
RE-DIRECTED IMMUNOTHERAPY |
摘要 |
The invention provides an agent for preventing or treating a condition characterised by the presence of unwanted cells, the agent comprising:
(i) a targeting moiety that is capable of targeting to the unwanted cells; and
(ii) a T cell antigen,
wherein the T cell antigen can be released from the targeting moiety by selective cleavage of a cleavage site in the agent in the vicinity of the unwanted cells. |
申请公布号 |
EP3138581(A1) |
申请公布日期 |
2017.03.08 |
申请号 |
EP20160191609 |
申请日期 |
2012.03.15 |
申请人 |
The University of Birmingham |
发明人 |
Cobbold,, Mark;Millar,, David |
分类号 |
A61K47/68;A61K39/12;A61K47/65;A61P35/00;A61P37/00 |
主分类号 |
A61K47/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|